Inactivation of NF-κB by EBV BZLF-1-encoded ZEBRA protein in human T cells

Journal of Immunology

Volumn 163, Issue 11, 1999, Pages 6261-6268

  Dreyfus, David H ^a   Nagasawa, Masayuki ^a   Pratt, Joanne C ^a   Kelleher, Colm A ^a   Gelfand, Erwin W ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL DNA; IMMEDIATE EARLY PROTEIN BZLF1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; VIRUS PROTEIN; BZLF1 PROTEIN, HERPESVIRUS 4, HUMAN; DNA BINDING PROTEIN; RECOMBINANT PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME INACTIVATION; EPSTEIN BARR VIRUS; GENE EXPRESSION; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; REPORTER GENE; T LYMPHOBLAST; VIRUS PATHOGENESIS; DRUG ANTAGONISM; GENETIC TRANSFECTION; GENETICS; LEUKEMIA CELL LINE; METABOLISM; PROTEIN BINDING; T LYMPHOCYTE; VIROLOGY;

DNA-BINDING PROTEINS; HERPESVIRUS 4, HUMAN; HUMANS; JURKAT CELLS; NF-KAPPA B; PROTEIN BINDING; RECOMBINANT PROTEINS; T-LYMPHOCYTES; TRANS-ACTIVATORS; TRANSFECTION; VIRAL PROTEINS;

EID: 0033248125     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Kieff, E. 1996. Epstein-Barr virus and its replication. In Fields Virology, Lippincott-Raven, Philadelphia, PA, p. 2343.
2. Rickinson, A. B., and E. Kieff. 1996. Epstein-Barr virus. In Fields Virology, Lippincott-Raven, Philadelphia, PA, p. 2397.
3. Anagnostopolous, I., M. Hummel, C. Kreschel, and H. Stein. 1995. Morphology, immuno-phenotype, and distribution of latently and/or productively Epstein-Barr virus infected cells in acute mononucleosis: implications for the inter-individual infection route of Epstein-Barr virus. Blood 85:744.
4. Jones, J. F., S. Shurin, C. Abramowsky, R. R. Tubbs, C. G. Sciotto, R. Wahl, J. Sands, D. Gottman, B. Z. Katz, and J. Sklar. 1988. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N. Engl. J. Med. 318:733.
5. Anagnostopolous, I., and M. Hummel. 1996. Epstein-Barr virus in tumors. Histopathology 29:297.
6. Su, I. J., R. L. Chen, D. T. Lin, K. S. Lin, and C. C. Chen 1994. Epstein-Barr virus infects T-lymphocytes in childhood EBV-associated hemophagocytic syndrome in Taiwan. Am. J. Path. 144:1219.
7. Sheldon, P. J., E. H. Hemsted, M. Papamichail, and E. J. Holborow. 1973. Thymic origin of atypical lymphoid cells in infectious mononucleosis. Lancet 1:1153.
8. Bishop, C. J., D. J. Moss, J. M. Ryan, and S. R. Burrows. 1985. T lymphocytes in infectious mononucleosis. II. Response in vitro to interleukin-2 and establishment of T cell lines. Clin. Exp. Immunol. 60:70.
9. + lymphocytes in Epstein-Barr virus-induced infectious mononucleosis. Blood 80:452.
10. Perez-Blas, M., J. R. Regueiro, J. Ruiz-Contreras, A. Arnaiz-Villena. 1992. T lymphocyte anergy during acute infectious mononucleosis is restricted to the clonotypic receptor activation pathway. Clin. Exp. Immunol. 89:83.
11. Sutkowski. N., T. Palkama, C. Ciurli, R. P. Sekaly, D. A. Thorley-Lawson, and B. T. Huber. 1996. An Epstein-Barr virus associated superantigen. J. Exp. Med. 180:971.
12. Watry, D., J. A. Hedrick, S. Siervo, G. Rhodes, J. J. Lamberti, J. D. Lambris, and C. D. Tsoukas. 1991. Infection of human thymocytes by Epstein-Barr virus. J. Exp. Med. 173:971.
13. Kaufman-Patterson, R. L., C. A. Kelleher, J. E. Streib, T. D. Amankonah, J. W. Xu, J. F. Jones, and E. W. Gelfand. 1995. Activation of human thymocytes after infection by EBV. J. Immunol. 154:1440.
14. Kaufman-Patterson, R. L., C. Kelleher, T. D. Amankonah, J. Streib, W. X. Xu, J. F. Jones, and E. W. Gelfand. 1995. Model of Epstein-Barr virus infection of human thymocytes: expression of viral genome and impact on cellular receptor expression in the T-lymphoblastic cell line, HPB-ALL. Blood 83:456.
15. Todd, S. C., and C. D. Tsoukas. 1996. EBV induces proliferation of immature human thymocytes in an IL-2-mediated response. J. Immunol. 156:4217.
16. + T lymphocytes by Epstein-Barr virus enhances human immunodeficiency virus expression. J. Virol. 70:7341.
17. Kelleher, C. A., R. Kaufman-Patterson, D. H. Dreyfus, J. E. Streib, J. W. Xu, K. Takase, J. F. Jones, and E. W. Gelfand. 1995. Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its repressor RAZ. Virology 203:685.
18. Fingeroth, J. D., M. L. Clabby, J. D. Strominger. 1988. Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21). J. Virol. 62:1442.
19. Sinha, S. K., S. C. Todd, J. A. Hedrick, C. L. Speiser, J. D. Lambris, and C. D. Tsoukas. 1993. Characterization of the EBV/C3d receptor on the human Jurkat T cell line. J. Immunol. 150:5311.
20. Tsoukas, C. D., and J. D. Lambris. 1993. Expression of EBV/C3d receptors on T cells: biological significance. Immunol. Today 14:56.
21. Chen, C., R. H. Sadler, D. M. Walling, I. Su, H. Hsieh, and N. Raab-Traub. 1993. Epstein-Barr virus (EBV) gene expression in EB V-positive peripheral T-cell lymphomas. J. Virol. 67:6303.
22. Yoshiyama, H., N. Shimizu, and K. Takada. 1995. Persistent Epstein-Barr virus infection in a human T-cell line: unique program of latent virus expression. EMBO J. 14:3706.
23. Peng, M., and E. Lundgren. 1993. Transient expression of the Epstein-Barr Virus LMP1 gene in B-cell chronic lymphocytic leukemia cells, T cells, and hematopoietic cell lines: cell-type-independent-induction of CD23, CD21, and ICAM-1. Leukemia 7:104.
24. Kawanishi, M. 1997. Expression of Epstein-Barr virus latent membrane protein 1 protects Jurkat T cells from apoptosis induced by serum deprivation. Virology 228:244.
25. Flamand, L., and J. Menezes. 1996. Cyclic AMP-responsive element-dependent activation of Epstein-Barr virus Zebra promoter by Human Herpesvirus 6. J. Virol. 70:1784.
26. Farrell, P. J., D. T. Rowe, C. M. Roooney, and T. Kouzarides. 1989. Epstein-Barr virus BZLF-1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos. EMBO J. 8:127.
27. Flemington, E., and S. H. Speck. 1990. Epstein-Barr virus BZLF1 trans-activator induces the promoter of a cellular cognate gene, c-fos. J. Virol. 64:4549.
28. Lieberman, P. M., J. M. Hardwick, J. Sample, G. S. Hayward, and S. D. Hayward. 1990. The Zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions. J. Virol. 64:1143.
29. Gutsch, D. E., E. A. Holley-Guthrie, Q. Zhang, B. Stein, M. A. Blanar, A. S. Baldwin, and S. C. Kenney. 1994. The bZIP transactivator of Epstein-Barr virus, BZLF-1, functionally and physically interacts with the p65 subunit of NF-κB. Mol. Cell Biol. 14:1939.
30. Hong, Y., E. A. Holley-Guthrie and S. C. Kenney. 1997. The bZIP dimerization domain of the Epstein-Barr virus BZLF-1 (Z) protein mediates lymphoid specific negative regulation. Virology 229:36.
31. Sista, N. D., C. Barry, K. Sampson, and J. S. Pagano. 1995. Physical and functional interaction of the Epstein-Barr virus BZLF1 transactivator with the retinoic acid receptors RARa and RXRa. Nucleic Acids Res. 23:1729.
32. Lieberman, P. M., and A. J. Berk. 1991. The Zta trans-activator protein stabilizes TFIID association with promoter DNA by direct protein-protein interaction. Genes Dev. 5:2441.
33. Kouzarides, T., C. Packham, A. Cook, and P. J. Farrell. 1991. The BZLF-1 protein of EBV has a coiled coil dimerisation domain without a heptad leucine repeat but with homology to the C/EBP leucine zipper. Oncogene 6:195.
34. Zhang, Q., D. Gutsch, and S.C. Kenney. 1994. Functional and physical interaction between p53 and BZLF-1: implications for Epstein-Barr virus latency. Mol. Cell Biol. 14:1929.
35. Bauerle, P. A., and D. Baltimore. 1988. IκBα: a specific inhibitor of the NF-κB transcription factor. Science 242:540.
36. Ganchi, P. A., S. C. Sun, W. C. Greene, and D. W. Ballard. 1992. IκBα/MAD-3 masks the nuclear localization signal of NF-κB p65 and requires the transactivation domain to inhibit NF-κB p65 DNA binding. Mol. Biol. Cell 3:1339.
37. Lenardo, M. J., and D. Baltimore. 1989. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58:227.
38. Barnes, P. J., and M. Karin. 1997. Nuclear factor κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066.
39. Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma. 1996. Suppression of TNF-α induced apoptosis by NF-κB. Science 274:787.
40. Esslinger, C. W., A. Wilson, B. Sordat, F. Beerman, and C. V. Jongeneel. 1997. Abnormal T lymphocyte development induced by targeted overexpression of IκBα. J. Immunol. 158:5075.
41. Hughes, C. C. W., and J. S. Pober. 1996. Transcriptional regulation of the interleukin-2 gene in normal human peripheral blood T cells. J. Biol. Chem. 271:5369.
42. Countryman, J., H. Jenson, R. Seibl, H. Wolf, and G. Miller. 1987. Polymorphic proteins encoded within BZLF-1 of defective and standard Epstein-Barr viruses disrupt latency. J. Virol. 61:3672.
43. Angel, P., M. Imagawa, R. Chiu, B. Stein, R. J. Imbra, H. J. Rahmsdorf, C. Jonat, P. Herrlich, and M. Karin. 1987. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729.
44. Minden, A., A. Lin, M. McMahon, C. Lange-Carter, B. Derijard, R. J. Davis, G. L. Johnson, and M. Karin. 1994. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266:1719.
45. Ghoda, L., X. Lin, and W. C. Greene. 1997. The 90-kDa ribosomal S6 kinase (pp90rsk) phosphorylates the N-terminal regulatory domain of IκBα and stimulates its degradation in vitro. J. Biol. Chem. 272:21281.
46. Jones, J. F., J. Streib, S. Baker, and M. Herberger. 1991. Chronic fatigue syndrome. I. Epstein-Barr virus immune response and molecular epidemiology. J. Med. Virol. 33:151.
47. Carey, M., J. Kolman, D. A. Katz, L. Gradoville, L. Barberis, and G. Miller. 1992. Transcriptional synergy by the Epstein-Barr virus transactivator BZLF-1. J. Virol. 66:4803.
48. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini-extracts" prepared from a small number of cells. Nucleic Acids Res. 17:6419.
49. Chodosh, L. A. 1994. Mobility shift DNA binding assay using gel electrophoresis. In Current Protocols in Molecular Biology. F. M. Ausabell, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, eds., J. Wiley, Boston, MA.
50. Lee, F. S., J. Hagler, Z. J. Chen, and T. Maniatis. 1997. Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88:213.
51. Henderson, S., M. Rowe, C. Gregory, D. Groom-Carter, F. Wang, R. Longnecker, E. Kieff, and A. Rickinson. 1991. Induction of Bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107.
52. Chen, W., and N. R. Cooper. 1996. Epstein-Barr virus nuclear antigen 2 and latent membrane protein independently transactivate p53 through induction of NF-κB activity. J. Virol. 70:4849.
53. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware, and E. Kieff, 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389.
54. Teodoro, J. G., and P. E. Branton. 1997. Regulation of apoptosis by viral gene products. J. Virol. 71:1739.
55. Neilan, J. G., Z. Lu, G. F. Kutish, L. Zsak, T. L. Lewis, and D. L. Rock. 1997. A conserved African swine fever virus IκB homolog, 5EL, is non-essential for growth in vitro and virulence in domestic swine. Virology 235:377.
56. Daibata, M., R. E. Humphreys, and T. Sairenji. 1992. Phosphorylation of the Epstein-Barr virus immediate-early gene product BZLF-1. Virology 188:916.
57. Kieff, E., and T. Shenk. 1998. Modulation of apoptosis by herpesviruses. Semin. Virol. 8:471.